SEMA3E and familial pancreatic carcinoma: Our findings point towards the potential use of Sema3E as a prognostic marker for predicting pancreatic cancer survival, as well as the potential targeting of Sema3E or its signaling pathways as a novel treatment for pancreatic cancer.